Skip to content
Company Analysis

Quest Diagnostics Incorporated DGX

A comprehensive view of key metrics, scores, and financial health for Quest Diagnostics Incorporated

Overview of Quest Diagnostics Incorporated

DGX NYQ
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics Large Cap
Quest Diagnostics Incorporated (DGX), is a Large Cap company, in the Diagnostics & Research industry, last closed at $203.06, about 19.1% overvalued vs fair value, +12.7% 1Y return, placing in the top 10% of its sector.
Metrics Rev Growth 11.8% ROE 14.2% Gross Margin 31.9%
USD 203.06
-0.38%
(Delayed)
• Vol 90d: 24.1%
52-Week Range
Market Cap
$22.56B
Enterprise Value
$28.72B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Good
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Good
Completeness: 82%
Confidence: 88%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://www.questdiagnostics.c...
HQ Secaucus, NJ
Employees 57,000
Fiscal year Dec 31

Next Events

Earnings Jul 21 Estimated
Dividend Jul 22 Ex-div: Jul 8

Fair Value Snapshot

Bear Base Bull
$145
$164
$184
Current: $203.06 -19% vs base

Engine Room Money Flow™

Large Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$11.0B
11.8%%
Gross Profit
$3.5B
8.6%%
Operating Income (GAAP)
$1.6B
19.1%%
EBITDA
$2.2B
15.8%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
31.9%
Poor

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$482.0M
53.0% of Free Cash Flow

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
2
Active Leaks
0/2
Improving
0
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Quest Diagnostics Incorporated's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
57
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Developing
38
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing DGX's balance between Growth (24.8%), Profitability (41.2%), and Safety (34.0%). Growth 25% Safety 34% Profitability 41%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

44th percentile vs peers
45
Key Signals
Rev Growth YoY 11.8% 60p Revenue CAGR 3Y 3.7% 40p EPS Growth YoY 2.0% 33p TSR 18.6% 65p EPS CAGR 3Y -20.9% 20p
Strengths
  • D/E Ratio in top 20% of peers (91.8%, 83th percentile)
  • Superior capital returns - 3 return metrics above peer median
  • Operating Margin in top 20% of peers (14.5%, 81th percentile)
Risks

No significant risks identified for this axis.

Profitability

74th percentile vs peers
74
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

61th percentile vs peers
61
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Quest Diagnostics Incorporated.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$164.29
- - -
-19.1% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000